Recent funding cuts by the US have raised alarms regarding the resurgence of tuberculosis (TB) and the effectiveness of global health programs. The WHO has warned that these cuts jeopardize significant progress made against TB, putting millions of lives at risk. While some aid has been restored and certain program cuts reversed, humanitarian groups are calling for clarity on the distribution of funds and pointing out that many services remain underfunded. Amid these challenges, the fight against drug-resistant TB is becoming increasingly concerning, prompting the WHO to urge the US to continue support until alternative resources are secured. The situation remains critical as many patients, like Kajol, struggle for access to necessary treatment amidst these uncertainties.